EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adenoid Hypertrophy in Children: Epidemiology, Pathophysiology, Clinical Manifestations, Diagnosis, and Contemporary Management

Mohammad Sharif Qazizada

Salamat Academic & Research Journal · 24.06.2026 · 3 (2) · 157-180

DOI: 10.61438/sarj.v3i2.296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Salamat Academic & Research Journal, online erschienen am 24.06.2026. Verfasst von Mohammad Sharif Qazizada. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Adenoid hypertrophy is a childhood condition and an important cause of nasal obstruction, mouth breathing, snoring, sleep-disordered breathing, and recurrent ear complaints. Persistent or severe disease may affect sleep, hearing, speech, craniofacial development, school performance, and quality of life. This narrative review summarizes current evidence on its epidemiology, pathophysiology, clinical presentation, diagnosis, management, outcomes, and evidence gaps.

Methods

A structured narrative review was conducted using PubMed/MEDLINE, Scopus, Web of Science, Google Scholar, and the Cochrane Library. Searches included terms related to adenoid hypertrophy, adenoiditis, pediatric nasal obstruction, sleep-disordered breathing, otitis media with effusion, chronic rhinosinusitis, allergic rhinitis, nasal endoscopy, radiography, intranasal corticosteroids, and adenoidectomy. Of 753 identified records, 573 were screened, 144 full-text reports were assessed, and 57 studies were included for thematic synthesis. Meta-analysis was not performed because of heterogeneity in study design, populations, diagnostic methods, interventions, and outcomes.

Results

Pediatric adenoid hypertrophy is a multifactorial condition influenced by normal lymphoid growth, recurrent infection, allergic inflammation, chronic mucosal irritation, biofilms, environmental exposure, and host susceptibility. Its effects may include nasal obstruction, mouth breathing, snoring, disturbed sleep, otitis media with effusion, hearing loss, chronic rhinosinusitis, hyponasal speech, craniofacial changes, and reduced quality of life. Flexible nasal endoscopy is preferred when available, while radiography, tympanometry, audiometry, symptom scores, and sleep assessment provide complementary information. Treatment should be individualized, ranging from observation and medical therapy to adenoidectomy for persistent, severe, or complicated disease.

Conclusion

Adenoid hypertrophy should be managed according to symptoms, objective obstruction, comorbid disease, treatment response, and family impact.

Zitieren

APA

Qazizada, M. S. (2026). Adenoid Hypertrophy in Children: Epidemiology, Pathophysiology, Clinical Manifestations, Diagnosis, and Contemporary Management. Salamat Academic & Research Journal, 3(2), 157-180. https://doi.org/10.61438/sarj.v3i2.296

Vancouver

Qazizada MS. Adenoid Hypertrophy in Children: Epidemiology, Pathophysiology, Clinical Manifestations, Diagnosis, and Contemporary Management. Salamat Academic & Research Journal. 2026;3(2):157-180. doi:10.61438/sarj.v3i2.296

BibTeX
@article{Qazizada2026,
  author = {Qazizada, Mohammad Sharif},
  title = {Adenoid Hypertrophy in Children: Epidemiology, Pathophysiology, Clinical Manifestations, Diagnosis, and Contemporary Management},
  journal = {Salamat Academic & Research Journal},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {157--180},
  doi = {10.61438/sarj.v3i2.296}
}
Kostenlos starten →